About Ar-Ex Laboratories Private Limited
Data last updated:
Ar-Ex Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 1956 and has been in existence for over 70 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1956PTC009736. Its GSTIN is 27AAACA4479N1Z8 (Maharashtra). The company holds 10 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹27.5 Lakh and a paid-up capital of ₹24.5 Lakh. It was formerly known as Ar-Ex Laboratories Limited. It is led by directors including Satish Narayan Gunjikar (Managing Director) and Ajit Narayan Gunjikar (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 10 Cama'S Land Mun. Ind Estate Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2025, the company reported a revenue of ₹115.46 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹15.86 Cr (net margin 13.7%) and EBITDA of ₹23.55 Cr (EBITDA margin 20.4%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 13% over five years.
The company has about 314 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Ar-Ex Laboratories. As per MCA filings, the company has open charges of ₹7.51 Cr and satisfied charges of ₹1.84 Cr on record. Court records list 18 cases involving the company, including 11 filed by the company and 7 filed against it; 4 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2014. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Bioaltus Pharmaceuticals Private Limited with revenue of ₹117.77 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arexlab.com.
Company details
Contact details
Ar-Ex Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is arexlab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 10 Cama'S Land Mun. Ind Estate Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ar-Ex Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ar-Ex Laboratories operates one associated brand: Ar-Ex Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations, APIs, and distribution services focused on healthcare in India. | arexlab.com |
Business activity
The main business activity of Ar-Ex Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ar-Ex Laboratories Private Limited, buy the company report.
Financials of Ar-Ex Laboratories Private Limited
FY 2025 filings availableAr-Ex Laboratories Private Limited reported revenue of ₹115.46 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 16% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.86 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.4% | ||||
| Net Profit Margin | 13.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ar-Ex Laboratories Private Limited, buy the company report.
Board of directors of Ar-Ex Laboratories Private Limited
Ar-Ex Laboratories has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Bhalchandra Mangaonkar Also directs: Bioxera Pharma Private Limited | Whole-Time Director | 01 Feb 2005 | 21 Years 8 Months | Current |
| Satish Narayan Gunjikar | Managing Director | 01 Aug 1989 | 37 Years 2 Months | Current |
| Ajit Narayan Gunjikar Also directs: Bioxera Pharma Private Limited, Ar-Ex Specialities Private Limited, Bioxera Drugs Private Limited and 2 more | Managing Director | 30 Jun 1982 | 44 Years 3 Months | Current |
| Sudha Narayan Gunjikar Also directs: Bioxera Pharma Private Limited | Whole-Time Director | 30 Jun 1982 | 44 Years 3 Months | Current |
Peer comparison
Ar-Ex Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioaltus Pharmaceuticals Private Limited | ₹117.77 Cr (FY 2025) | 26.0% | Thane, Maharashtra, India | |||
| Westcoast Pharmaceutical Works Limited | ₹117.56 Cr (FY 2024) | -3.0% | Ahmedabad, Gujarat, India | |||
| Crius Life Sciences Private Limited | ₹116.77 Cr (FY 2025) | 3.0% | Nalagarh, Himachal Pradesh, India | |||
| Kerala State Drugs and Pharmaceuticals Ltd | ₹116.23 Cr (FY 2024) | 41.0% | Alappuzha, Kerala, India | |||
| Ar-Ex Laboratories Private Limitedthis company | ₹115.46 Cr (FY 2025) | ₹15.86 Cr | 13.7% | 16.0% | 314 | Mumbai, Maharashtra, India |
| Pharose Remedies Limited | ₹115.39 Cr (FY 2025) | 4.0% | Punjab, India | |||
| Biogenetic Drugs Private Limited | ₹115.34 Cr (FY 2025) | -2.0% | Jaipur, Rajasthan, India | |||
| Synthokem Labs Private Limited | ₹113.98 Cr (FY 2024) | 2.0% | Patancheru, Telangana, India |
To see the full peer comparison of Ar-Ex Laboratories Private Limited, buy the company report.
Auditor
Ar-Ex Laboratories Private Limited is audited by R. U. Kamath & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. U. Kamath & Co | FY 2023 | 034431 |
Shareholding
The shareholding of Ar-Ex Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ar-Ex Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Mar 2012 | 10347825 | The Saraswat Co-Operative Bank Ltd | ₹25 Lakh | Open | |
| 09 Mar 2012 | 10347823 | The Saraswat Co-Operative Bank Ltd | ₹25 Lakh | Open | |
| 29 Mar 2006 | 100184910 | The Saraswat Co-Op Bank Ltd | ₹2.2 Cr | Open | |
| 16 Nov 2002 | 90218477 | The Saraswat Co-Operative Bank Ltd. | ₹4.5 Cr | Open | |
| 09 Jan 1991 | 90216160 | The Maharashtra State Finance Corpn. | ₹25 Lakh | Open |
To see the full charge records of Ar-Ex Laboratories Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Ar-Ex Laboratories Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2014.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ar-Ex Laboratories Private Limited has 18 court cases on record: 11 filed by Ar-Ex Laboratories, 7 filed against it. 4 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 5 | 2 |
| High courts | 9 | 2 | 2 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Konsyl Pharmaceuticals Pvt Ltd and 1 other | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Konsyl Pharmaceuticals Pvt Ltd and 1 other | Disposed |
| Bombay High Court | Court case (LPETN) | Filed by the company against Konsyl Pharmaceuticals Pvt Ltd | Disposed |
| High Court of Karnataka | Appeal | Filed by the company against M/S Elder Pharmaceuticals Ltd | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Elder Pharmaceuticals Ltd | Disposed |
To see the full case history of Ar-Ex Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ar-Ex Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Ar-Ex Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Ar-Ex Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Bioxera Pharma Private Limited | U24230MH2005PTC156737 |
To see the full group structure of Ar-Ex Laboratories Private Limited, buy the company report.
Employees & EPFO
Ar-Ex Laboratories Private Limited has a workforce of 314 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Ar-Ex Laboratories has 10 GST registrations: 1 active and 9 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA4479N1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ar-Ex Laboratories Private Limited, buy the company report.
Recent activity
Ar-Ex Laboratories Private Limited has 7 board changes on record since 1982: 4 appointments and 3 cessations. The latest: Nitin Bhalchandra Mangaonkar ceased to be Director on 01 Dec 2014.
27 earlier events are in the company report.
Frequently asked questions
Ar-Ex Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 1956 (70+ years old) and is registered under CIN U24239MH1956PTC009736.
Ar-Ex Laboratories has 4 current directors:
- Satish Narayan Gunjikar - Managing Director
- Ajit Narayan Gunjikar - Managing Director
- Nitin Bhalchandra Mangaonkar - Whole-Time Director
- Sudha Narayan Gunjikar - Whole-Time Director
The latest financial statements of Ar-Ex Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ar-Ex Laboratories is 27AAACA4479N1Z8, registered in Maharashtra. The company has 10 GST registrations in all, of which 1 is active and 9 are cancelled or inactive.
The CIN (Corporate Identification Number) of Ar-Ex Laboratories is U24239MH1956PTC009736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ar-Ex Laboratories has 18 court cases on record: 11 filed by the company and 7 filed against it. 4 are pending. Most are in the district courts.
Ar-Ex Laboratories was incorporated on 03 March 1956, making it 70+ years old. It is registered with the Registrar of Companies, Mumbai.
Ar-Ex Laboratories has 1 deal on record (1 secondary share transfer); the latest was in March 2014.
The peers of Ar-Ex Laboratories by revenue are Bioaltus Pharmaceuticals Private Limited, Westcoast Pharmaceutical Works Limited, Crius Life Sciences Private Limited, Kerala State Drugs and Pharmaceuticals Ltd, Pharose Remedies Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nitin Bhalchandra Mangaonkar ceased to be Director on 01 Dec 2014. Satish Narayan Gunjikar ceased to be Director on 01 Dec 2014. Sudha Narayan Gunjikar ceased to be Director on 01 Dec 2014. Ar-Ex Laboratories has 7 board changes on record in total.
Ar-Ex Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.
Ar-Ex Laboratories can be reached through the website arexlab.com. Its registered office is in Mumbai, Maharashtra, India.